INDUSTRIES WE SERVE
Expertise Across the Pharmaceutical Spectrum
Prime Pharma Partners leads execution in complex GMP manufacturing programs across regulated pharmaceutical and biotechnology sectors, establishing program‑level CQV control during critical startup and GMP readiness phases.
Sterile Injectable Manufacturing
Sterile injectable programs operate under converging aseptic risk, regulatory scrutiny, and aggressive startup timelines. Prime Pharma Partners leads CQV execution by establishing program control, aligning cross-functional teams, and driving disciplined execution from construction completion through GMP readiness.
Common Engagement Triggers
Isolator or aseptic process readiness under compressed timelines.
APS / media fill execution tied to critical GMP milestones.
Inspection readiness gaps emerging as GMP release approaches.
Cell and Gene Therapy Facilities
Advanced therapy programs operate within highly compressed timelines, novel manufacturing approaches, and heightened regulatory scrutiny. Prime Pharma Partners is engaged to establish execution control, align CQV strategy to operational reality, and drive readiness in environments where margin for error is minimal.
Common Engagement Triggers
Rapid facility or process scale‑up under aggressive delivery timelines.
Limited historical data driving uncertainty in validation and readiness.
High inspection risk due to program novelty and complexity.
Biologics Production
Biologics manufacturing programs introduce added complexity through biologically derived processes, tight process tolerances, and evolving regulatory expectations. Prime Pharma Partners leads execution where control, alignment, and disciplined CQV delivery are required to ensure predictable GMP readiness and inspection outcomes.
Common Engagement Triggers
Complex process integration across upstream, downstream, and support systems.
CQV scope misalignment impacting readiness milestones.
Cross‑functional execution challenges affecting startup confidence.
Vaccine Manufacturing
Vaccine manufacturing programs frequently operate under accelerated timelines, global regulatory expectations, and tight delivery commitments tied to public health demand. Prime Pharma Partners leads CQV execution in vaccine facilities by establishing execution discipline, aligning cross‑functional teams, and maintaining program control as organizations progress toward commercial readiness.
Common Engagement Triggers
Platform readiness and schedule‑driven qualification under compressed timelines.
CQV execution requiring integrated scheduling and milestone control to protect delivery dates.
Cross‑functional dependencies introducing risk to commercial readiness commitments.
Advanced Therapy Medicinal Products
ATMP manufacturing programs introduce novel platforms, evolving regulatory expectations, and increased technical uncertainty during facility startup. Prime Pharma Partners is engaged to apply program‑level CQV governance, maintain execution control, and manage readiness risk across emerging manufacturing models where speed and compliance must advance together.
Common Engagement Triggers
Tailored validation and readiness approaches required for novel modalities.
Rapid alignment needed across systems, documentation, and operations.
Execution uncertainty during startup creating GMP readiness or inspection risk.
HOW WE SUPPORT
Programs Across These Industries
Most CQV support focuses on documentation and execution. Prime Pharma Partners operates at the program level, establishing execution strategy, enforcing governance, and maintaining control across all phases of delivery.
✔ Cross-functional alignment across Engineering, Automation, Quality, MS&T, and Manufacturing
✔ Execution structured to deliver inspection-ready GMP release
✔ Controlled transition from construction into GMP operations.
✔ Program‑level CQV leadership and execution governance.
What Success Looks Like
Clear Readiness Gates:
Defined prerequisites, accountable ownership, and unambiguous completion criteria aligned to readiness milestones.
1
Predictable CQV Completion:
Sequenced execution and program control that maintains momentum through qualification and closeout.
2
Inspection-Ready Documentation:
Complete, traceable evidence packages aligned with site quality systems and regulatory expectations.
3
Cross‑Functional Alignment:
Engineering, MS&T, Automation, Quality, and Manufacturing operating to a unified plan and execution cadence.
4
YOUR INDUSTRY
Don’t See Your Area?
Our team has broad experience across the full pharmaceutical landscape. Reach out and let's discuss your specific needs.